Sustained‐release ibuprofen prodrug particle: Emulsifier and initiator regulate the diameter and distribution | Zendy

Wang Jia | Zendy; Zhang Haixin | Zendy; Xu Jie | Zendy; Qian Hao | Zendy; Liu Rui | Zendy; Xu Zengchang | Zendy; Zhu Hongjun | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Sustained‐release ibuprofen prodrug particle: Emulsifier and initiator regulate the diameter and distribution

Author(s) -

Wang Jia,

Zhang Haixin,

Xu Jie,

Qian Hao,

Liu Rui,

Xu Zengchang,

Zhu Hongjun

Publication year - 2021

Publication title -

journal of applied polymer science

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.575

H-Index - 166

eISSN - 1097-4628

pISSN - 0021-8995

DOI - 10.1002/app.49779

Subject(s) - dispersity , ethylene glycol dimethacrylate , materials science , monomer , ethylene glycol , polymer chemistry , drug delivery , emulsion polymerization , fourier transform infrared spectroscopy , polymer , chemical engineering , methyl methacrylate , particle size , emulsion , chemistry , organic chemistry , methacrylic acid , nanotechnology , composite material , engineering

Polymers have played a vital part in the development of drug delivery systems (DDS). For DDS, having a controllable diameter and distribution are conducive to reproducibility of drug release behavior and efficacy. In this work, an ibuprofen prodrug (Ibu@PMMA) was synthesized by methyl methacrylate (MMA), ibuprofen monomer (Ibu@HEMA), and ethylene glycol dimethacrylate (EGDMA) via emulsion polymerization. The Ibu@PMMA exhibits spherical shapes, and its structural properties were characterized by NMR, FTIR, and SEM techniques. In addition, the hydrodynamic diameter and polydispersity index (PDI) of Ibu@PMMA were reduced by increasing the proportion of emulsifier. Meanwhile, by increasing the amount of initiator, the hydrodynamic diameter and PDI of Ibu@PMMA were decreased. Moreover, Ibu@PMMA exhibits good sustained‐release ability in vitro , which could be used as a potential delivery system for anti‐inflammatory agents.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research